5.4 Patient Assessment, Self-Care & Point-of-Care Testing
Key Takeaways
- Person-Centered Assessment explicitly includes medication and allergy reconciliation, health screening, OTC and dietary-supplement self-care triage, and use of administration devices and self-monitoring tools.
- Medication reconciliation compares the patient's actual medication list against orders at every transition of care to catch omissions, duplications, and dosing errors.
- OTC self-care triage means recognizing red-flag symptoms that exceed self-treatment and require referral rather than recommending a nonprescription product.
- Pharmacists interpret point-of-care and self-monitoring data (blood pressure, blood glucose/HbA1c, INR, lipid panels) and counsel on correct device technique.
- Many dietary supplements and herbal products have clinically important interactions (e.g., St. John's wort induces CYP3A4; high-dose vitamin K antagonizes warfarin).
Assessment as the Front Door of Person-Centered Care
The Person-Centered Assessment and Treatment Planning domain (40%) is not only disease-state therapeutics; it explicitly includes assessment activities — reconciliation, screening, self-care triage, supplement evaluation, and interpreting self-monitoring data. These are recurring item types where the best answer is to gather or verify information, or refer, rather than immediately recommend a drug.
Medication and Allergy Reconciliation
Medication reconciliation is the process of creating the most accurate possible list of everything a patient is taking — prescriptions, OTCs, supplements, doses, routes, frequencies — and comparing it against what is ordered at each transition of care (admission, transfer, discharge). It catches:
- Omissions — a chronic medication left off after hospitalization
- Duplications — two agents in the same class
- Dose/frequency discrepancies and route errors
- Allergy gaps — distinguishing a true allergy (e.g., hives, anaphylaxis) from an intolerance (e.g., nausea), which changes whether an entire drug class is truly off-limits
Accurate allergy documentation prevents both unsafe exposure and unnecessary avoidance of first-line therapy.
Interpreting Common Labs and Reference Ranges
Person-centered assessment requires reading basic labs to judge therapy appropriateness, dosing, and monitoring. Know the direction a value should move and what is actionable.
| Lab | Approximate adult reference | Pharmacy relevance |
|---|---|---|
| Serum potassium | 3.5-5.0 mEq/L | High with ACEi/ARB/MRA/K-supplements; low with loop/thiazide diuretics |
| Serum creatinine / eGFR | SCr ~0.6-1.2 mg/dL | Drives renal dose adjustment (Cockcroft-Gault) and drug avoidance |
| Potassium and sodium | Na 135-145 mEq/L | Hyponatremia with thiazides, SSRIs, carbamazepine |
| INR | ~2-3 for most warfarin indications | High INR + bleeding is urgent; supratherapeutic needs dose hold/vitamin K |
| HbA1c | Goal often <7% (individualized) | Reflects ~3-month glucose; guides diabetes intensification |
| ANC | Neutropenia <1,500/microL | Drives clozapine, chemotherapy, and infection monitoring |
| Hepatic enzymes (ALT/AST) | Roughly up to ~40 U/L | Rising values flag hepatotoxic drugs (statins, isoniazid, acetaminophen) |
Exam cue: A lab value alone is rarely the answer; the question is usually what to do with it - hold a drug, adjust a dose, refer, or monitor.
Health Screening and Physical-Assessment Basics
Pharmacists increasingly screen and triage. The exam expects recognition of normal versus actionable findings and the appropriate response.
| Parameter | Actionable concept |
|---|---|
| Blood pressure | Confirm elevated readings; recognize a hypertensive emergency (acute target-organ damage) needing urgent referral |
| Blood glucose / HbA1c | HbA1c reflects ~3-month average control; recognize hypo- and hyperglycemia symptoms |
| INR | Therapeutic range for most warfarin indications is about 2-3; a high INR with bleeding is urgent |
| Lipid panel | Interpret in the context of overall ASCVD risk, not LDL-C alone |
| Temperature / signs of infection | Fever with neutropenia or sepsis features needs emergency care |
The pharmacist's role is to screen, counsel, and refer, working within scope and collaborative agreements rather than diagnosing independently.
OTC Self-Care Triage and Referral Red Flags
Nonprescription product recommendations are a high-yield, frequently tested skill. Structured triage (such as the QuEST/SCHOLAR approach — explore Symptoms, Characteristics, History, Onset, Location, Aggravating/Remitting factors) determines whether self-care is appropriate or referral is required.
Common red flags that exceed self-treatment and warrant referral:
- Symptoms lasting beyond the OTC label's stated duration, or worsening despite therapy
- High fever, severe or escalating pain, or signs of a serious infection
- Symptoms in high-risk groups (young infants, pregnancy, significant comorbidity, immunosuppression)
- "Alarm" features: blood in stool/vomit/urine, chest pain, shortness of breath, neurologic changes, unintended weight loss, dehydration in the very young or old
Exam cue: When a self-care vignette contains a red flag (e.g., a 4-week cough with weight loss, or diarrhea with blood and high fever), the correct answer is refer to a provider, not pick an OTC product.
Dietary Supplements and Herbal Interactions
Supplements are part of the medication list and carry real interactions the NAPLEX tests:
| Supplement | Key concern |
|---|---|
| St. John's wort | Potent CYP3A4 (and P-glycoprotein) inducer; lowers levels of many drugs (oral contraceptives, certain immunosuppressants, some HIV/oncology agents) and adds serotonergic risk |
| Vitamin K-rich products / high-dose vitamin K | Antagonize warfarin; emphasize consistency, not strict avoidance |
| Ginkgo, garlic, high-dose fish oil, vitamin E | Additive bleeding risk with antiplatelets/anticoagulants |
| Potassium-containing salt substitutes | Additive hyperkalemia with ACEi/ARB/MRA |
| Calcium, iron, magnesium, antacids | Chelate and reduce absorption of levothyroxine, fluoroquinolones, tetracyclines |
Counsel patients that "natural" does not mean inert or safe, and that supplements are not held to the same premarket standard as approved drugs.
Point-of-Care Testing and Self-Monitoring Devices
Pharmacists interpret point-of-care (POC) results and teach patients to use self-monitoring devices correctly — a named competency (administration devices and self-monitoring tools).
- Home blood pressure monitors: correct cuff size and arm position, rest before measuring, multiple readings averaged.
- Blood glucose meters and continuous glucose monitors (CGMs): technique, calibration where applicable, and recognizing readings that need action.
- Inhalers, spacers, and peak-flow meters: device technique directly affects control (see pulmonary section).
- Injectable device counseling: insulin pens, GLP-1 agonist pens, epinephrine autoinjectors — site rotation, priming, and storage.
- POC tests (rapid strep, influenza, INR, A1c, lipid, COVID-19) support screening and therapy decisions within scope.
Counseling pearl: Apparent "treatment failure" is frequently a device-technique problem. Before escalating therapy, verify the patient is using the device correctly with a teach-back or return demonstration.
A 25-year-old otherwise healthy patient asks for an OTC cough product. On questioning, the cough has lasted 5 weeks, with night sweats and a 10-pound unintentional weight loss. What is the most appropriate action?
A patient stabilized on warfarin begins taking St. John's wort for low mood. What is the most likely consequence the pharmacist should anticipate?
During medication reconciliation at hospital discharge, a pharmacist notes the patient's home metoprolol was inadvertently omitted from the discharge orders. What does this finding best represent, and what is the appropriate step?
A patient on lisinopril and spironolactone for heart failure has a new serum potassium of 6.1 mEq/L. What does the pharmacist do with this value?